PMID: 24857923

Zhou D, Liu Y, Zhang X, Gu X, Wang H, Luo X, Zhang J, Zou H, Guan M
Functional polymorphisms of the ABCG2 gene are associated with gout disease in the Chinese Han male population.
Int J Mol Sci. 2014 May 22;15(5):9149-59. doi: 10.3390/ijms15059149., [PubMed]
Sentences
No. Mutations Sentence Comment
5 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:5:114
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:5:108
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:5:124
status: NEW
view ABCG2 p.Gln126* details
High-resolution melting analysis and Sanger sequencing were performed to identify the genetic polymorphisms V12M, Q141K and Q126X in the ABCG2 gene. Login to comment
7 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:7:125
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:7:115
status: NEW
view ABCG2 p.Gln126* details
A prediction model for gout risk using ABCG2 protein function was established based on the genotype combination of Q126X and Q141K. Login to comment
8 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:8:13
status: NEW
view ABCG2 p.Gln141Lys details
Results: For Q141K, the A allele OPEN ACCESS frequency was 49.6% in the gout patients and 30.9% in the controls (OR 2.20, 95% confidence interval (CI): 1.77-2.74, p = 8.99 &#d7; 10-13 ). Login to comment
9 ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:9:10
status: NEW
view ABCG2 p.Gln126* details
Regarding Q126X, the T allele frequency was 4.7% in the gout patients and 1.7% in the controls (OR 2.91, 95% CI: 1.49-5.68, p = 1.57 &#d7; 10-3 ). Login to comment
10 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:10:27
status: NEW
view ABCG2 p.Val12Met details
The A allele frequency for V12M was lower (18.3%) in the gout patients than in the controls (29%) (OR 0.55, 95% CI 0.43-0.71, p = 2.55 &#d7; 10-6 ). Login to comment
11 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:11:32
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:11:16
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:11:22
status: NEW
view ABCG2 p.Gln126* details
In the order of V12M, Q126X and Q141K, the GCA and GTC haplotypes indicated increased disease risk (OR = 2.30 and 2.71, respectively). Login to comment
33 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:33:22
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:33:32
status: NEW
view ABCG2 p.Gln126* details
Furthermore, the SNPs Q141K and Q126X in the human ABCG2 gene have recently been recognized as clinical biomarkers to assess hyperuricemia and gout. Login to comment
37 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:37:81
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:37:88
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:37:97
status: NEW
view ABCG2 p.Gln126* details
In the present study, we developed an HRM assay to detect three functional SNPs (Q141K, V12M and Q126X) and then assessed the genetic association of those SNPs in the ABCG2 gene with gout to investigate the association between ABCG2 dysfunction and gout risk in a Han Chinese male population. Login to comment
42 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:42:154
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:42:161
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:42:170
status: NEW
view ABCG2 p.Gln126* details
The results obtained from the DNA sequencing analysis confirmed the reliability of the HRM assay. The genotype and allelic frequencies of the three SNPs (Q141K, V12M and Q126X) among the cases and controls were in Hardy-Weinberg equilibrium for all of the polymorphisms analyzed. Login to comment
43 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:43:4
status: NEW
view ABCG2 p.Gln141Lys details
For Q141K, the A allele was found on 49.6% of the chromosomes from the gout patients compared with 30.9% of the chromosomes from the controls (OR 2.20, 95% CI: 1.77-2.74, p = 8.99 &#d7; 10-13 ). Login to comment
44 ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:44:10
status: NEW
view ABCG2 p.Gln126* details
Regarding Q126X, the T allele was found on 4.7% of the chromosomes from the gout patients compared with 1.7% of the chromosomes from the controls (OR 2.91, 95% CI: 1.49-5.68, p = 1.57 &#d7; 10-3 ). Login to comment
45 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:45:190
status: NEW
view ABCG2 p.Val12Met details
The results of the association study, shown in Table 1, demonstrate that 141K and 126X were significantly associated with an increased risk of gout, whereas the frequency of the A allele of V12M appeared to be significantly decreased in gout patients (18.3%) compared with controls (29%) (OR 0.55, 95% CI: 0.43-0.71). Login to comment
48 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:48:70
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:48:45
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:48:55
status: NEW
view ABCG2 p.Gln126* details
The three groups are well distinguished: (A) V12M; (B) Q126X; and (C) Q141K. Login to comment
54 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:54:108
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:54:279
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:54:196
status: NEW
view ABCG2 p.Gln126* details
SNP Genotype * Allele Frequency Mode Case Control p-Value p-Value OR 95% CI 1/1 1/2 2/2 MAF 1/1 1/2 2/2 MAF Q141K 84 181 87 0.496 33 150 167 0.309 1.18 &#d7; 10-11 8.99 &#d7; 10-13 2.20 1.77-2.74 Q126X 0 33 319 0.047 0 12 338 0.017 1.31 &#d7; 10-3 1.57 &#d7; 10-3 2.91 1.49-5.68 V12M 16 97 239 0.183 35 133 182 0.290 3.67 &#d7; 10-5 2.55 &#d7; 10-6 0.55 0.43-0.71 * The minor allele was referred to as allele 1, and the major allele was referred to as allele 2. Login to comment
55 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:55:35
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:55:77
status: NEW
view ABCG2 p.Gln126* details
Allele 1 is A and allele 2 is C in Q141K. Allele 1 is T and allele 2 is C in Q126X. Login to comment
56 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:56:35
status: NEW
view ABCG2 p.Val12Met details
Allele 1 is A and allele 2 is G in V12M. Login to comment
58 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:58:89
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:58:73
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:58:79
status: NEW
view ABCG2 p.Gln126* details
Haplotype Analysis We performed a 3-SNP haplotype analysis (in the order V12M, Q126X and Q141K). Login to comment
63 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:63:48
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:63:101
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:63:32
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:63:90
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:63:38
status: NEW
view ABCG2 p.Gln126* details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:63:95
status: NEW
view ABCG2 p.Gln126* details
Haplotype frequency analysis of V12M, Q126X and Q141K. Allele Frequency p-Value OR 95% CI V12M Q126X Q141K Gout Control G C A 0.481 0.289 1.26 &#d7; 10-13 2.30 1.84-2.87 G T C 0.044 0.017 2.97 &#d7; 10-3 2.71 1.37-5.36 G C C 0.292 0.404 8.27 &#d7; 10-6 0.60 0.48-0.75 A C C 0.165 0.271 1.53 &#d7; 10-6 0.53 0.41-0.69 2.3. Login to comment
74 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:74:69
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:74:75
status: NEW
view ABCG2 p.Gln126* details
Estimated Function Genotype Combination Number (%) p-Value OR 95% CI Q141K Q126X Gout Control ࣘ1/4 function C/A T/C 22 (6.2) 8 (2.3) 8.47 &#d7; 10-6 5.90 2.56-13.58 1/2 function C/C T/C 95 (27.0) 37 (10.5) 1.12 &#d7; 10-13 5.51 3.46-8.77 A/A C/C 3/4 function C/A C/C 159 (45.2) 142 (40.6) 1.00 &#d7; 10-6 2.40 1.69-3.42 Full function C/C C/C 76 (21.6) 163 (46.6) ߟ ߟ p-Value, OR and 95% CI for each ABCG2 dysfunction were obtained via comparisons with full function. Login to comment
76 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:76:245
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:76:262
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:76:252
status: NEW
view ABCG2 p.Gln126* details
Discussion This study is the first to examine the possible role of ABCG2 variants, which have previously been found to be associated with gout, in terms of their genetic susceptibility to gout in the Han Chinese population. We found that the Q141K, Q126X and V12M alleles were strongly associated with gout in Chinese males. Login to comment
86 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:86:266
status: NEW
view ABCG2 p.Val12Met details
Consistent with the genetic susceptibility identified in gout patients in a cohort of Japanese individuals [18], we observed that the rare alleles of both the 141K and 126X SNPs of ABCG2 were associated with an increased risk for gout, whereas the minor A allele in V12M had a protective effect on susceptibility to gout. Login to comment
87 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:87:4
status: NEW
view ABCG2 p.Gln141Lys details
The Q141K SNP has been extensively studied; it has been found to impair protein-nucleotide binding stability [28], which has been linked to hyperuricemia in a variety of populations [29]. Login to comment
91 ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:91:33
status: NEW
view ABCG2 p.Gln126* details
The other nonfunctional variant, Q126X, is consistently observed in certain Japanese and Korean cohorts [18,32]. Login to comment
93 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:93:54
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:93:44
status: NEW
view ABCG2 p.Gln126* details
These findings reflect the diversity of the Q126X and Q141K distributions in different ethnic populations, which may explain the different prevalence of gout in Chinese and Caucasian populations. Login to comment
94 ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:94:34
status: NEW
view ABCG2 p.Gln126* details
Among the 352 patients with gout, Q126X heterozygous (n = 33) mutations were found that revealed that non-functional 126X dramatically increased gout risk (OR 2.91). Login to comment
96 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:96:74
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:96:64
status: NEW
view ABCG2 p.Gln126* details
Matsuo et al. [16,18] reported that the genotype combination of Q126X and Q141K is a clinically important biomarker for predicting gout risk in the Japanese population. We analyzed the relationship between ABCG2 transport dysfunction and gout and found that dysfunctional ABCG2 is responsible for approximately 78.4% of gout cases. Login to comment
115 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:115:57
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:115:41
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:115:47
status: NEW
view ABCG2 p.Gln126* details
We selected three functional ABCG2 SNPs: V12M, Q126X and Q141K. Login to comment
124 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:124:98
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 24857923:124:40
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:124:157
status: NEW
view ABCG2 p.Gln126* details
SNP ID SNP Allele Sequence (5'-3') Size V12M A/G ATGGTATGGGCCATTCATTG 250 bp ATGCCTTCAGGTCATTGGAA Q141K A/C ATGTTGTGATGGGCACTCTG 158 bp CCACATTACCTTGGAGTCTG Q126X C/T GCTGCAAGGAAAGATCCAAG 163 bp CAGCCAAAGCACTTACCCAT 4.3. Login to comment
137 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 24857923:137:46
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 24857923:137:56
status: NEW
view ABCG2 p.Gln126* details
The recent findings on the roles of the ABCG2 Q141K and Q126X polymorphism in gout may pave the way for pharmacological chaperones targeting ABCG2 as a potential new therapeutic target for gout. Login to comment